Therapeutic targeting of autophagy in myocardial infarction and heart failure

Expert Review of Cardiovascular Therapy

Volumn 14, Issue 9, 2016, Pages 1007-1019

  Riquelme, Jaime A ^a   Chavez, Myra N ^a,b   Mondaca Ruff, David ^a   Bustamante, Mario ^a,c   Vicencio, Jose Miguel ^a,d   Quest, Andrew F G ^a   Lavandero, Sergio ^a,e  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Autophagy; cell death; heart failure; ischemia reperfusion; myocardial infarction; pharmacological target

Indexed keywords

AUTOPHAGY; CLINICAL FEATURE; DRUG TARGETING; HEART DEVELOPMENT; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HUMAN; MUSCLE REGENERATION; NONHUMAN; REVIEW; ANIMAL; CARDIAC MUSCLE; MYOCARDIAL INFARCTION; PATHOLOGY;

ANIMALS; AUTOPHAGY; HEART FAILURE; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIUM;

EID: 84983434219     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1080/14779072.2016.1202760     Document Type: Review

References (138)

1. World Health Organization. Global health estimates:deaths by cause, age, sex and country, 2000–2012. Geneva:WHO; 2014 [Internet]. Available from:http://www.who.int/healthinfo/global_burden_disease/estimates/en/index1.html
2. D.J.Hausenloy, H.Erik Botker, G.Condorelli, et al. Translating cardioprotection for patient benefit:position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res. 2013;98(1):7–27.
3. D.J.Hausenloy, D.M.Yellon Ischaemic conditioning and reperfusion injury. Nat Rev Cardiol. 2016;13(4):193–209.
4. K.Thygesen, J.S.Alpert, H.D.White, et al. Universal definition of myocardial infarction. Circulation. 2007;116(22):2634–2653.
5. T.T.Cung, O.Morel, G.Cayla, et al. Cyclosporine before PCI in patients with acute myocardial infarction. N Engl J Med. 2015;373(11):1021–1031.
6. D.O.Okonko, A.M.Shah. Heart failure:mitochondrial dysfunction and oxidative stress in CHF. Nat Rev Cardiol. 2015;12(1):6–8.
7. A.P.Ambrosy, G.C.Fonarow, J.Butler, et al. The global health and economic burden of hospitalizations for heart failure:lessons learned from hospitalized heart failure registries. J Am Coll Cardiol. 2014;63(12):1123–1133.
8. A.E.Moran, M.H.Forouzanfar, G.A.Roth, et al. The global burden of ischemic heart disease in 1990 and 2010:the Global Burden of Disease 2010 study. Circulation. 2014;129(14):1493–1501.
9. B.Ibanez, G.Heusch, M.Ovize, et al. Evolving therapies for myocardial ischemia/reperfusion injury. J Am Coll Cardiol. 2015;65(14):1454–1471.
10. V.Sivaraman, D.M.Yellon. Pharmacologic therapy that simulates conditioning for cardiac ischemic/reperfusion injury. J Cardiovasc Pharmacol Ther. 2014;19(1):83–96.
11. J.S.Alpert, K.Thygesen, E.Antman, et al. Myocardial infarction redefined–a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36(3):959–969.
12. D.J.Hausenloy, D.M.Yellon. Myocardial ischemia-reperfusion injury:a neglected therapeutic target. J Clin Invest. 2013;123(1):92–100.• Describes the pathophysiological mechanisms involved in ischemia–reperfusion injury.
13. A.P.Halestrap, S.J.Clarke, S.A.Javadov. Mitochondrial permeability transition pore opening during myocardial reperfusion–a target for cardioprotection. Cardiovasc Res. 2004;61(3):372–385.
14. A.M.Shah, D.L.Mann. In search of new therapeutic targets and strategies for heart failure:recent advances in basic science. Lancet. 2011;378(9792):704–712.• Describes the pathophysiological mechanisms mediating heart failure (and therapeutic strategies to approach its treatment).
15. G.G.Schiattarella, F.Magliulo, F.Cattaneo, et al. Novel molecular approaches in heart failure:seven trans-membrane receptors signaling in the heart and circulating blood leukocytes. Front Cardiovasc Med. 2015;2:13.
16. C.W.Yancy, M.Jessup, B.Bozkurt, et al. 2013 ACCF/AHA guideline for the management of heart failure:a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;62(16):e147–e239.
17. J.M.Vicencio, S.Lavandero, G.Szabadkai. Ca2+, autophagy and protein degradation:thrown off balance in neurodegenerative disease. Cell Calcium. 2010;47(2):112–121.
18. S.Lavandero, R.Troncoso, B.A.Rothermel, et al. Cardiovascular autophagy:concepts, controversies, and perspectives. Autophagy. 2013;9(10):1455–1466.
19. B.Levine, G.Kroemer. Autophagy in the pathogenesis of disease. Cell. 2008;132(1):27–42.
20. J.M.Vicencio, L.Galluzzi, N.Tajeddine, et al. Senescence, apoptosis or autophagy? When a damaged cell must decide its path–a mini-review. Gerontology. 2008;54(2):92–99.
21. K.H.Kim, M.S.Lee. Autophagy–a key player in cellular and body metabolism. Nat Rev Endocrinol. 2014;10(6):322–337.
22. J.Kim, M.Kundu, B.Viollet, et al. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol. 2011;13(2):132–141.
23. A.M.Choi, S.W.Ryter, B.Levine. Autophagy in human health and disease. N Engl J Med. 2013;368(7):651–662.
24. D.J.Klionsky, P.Codogno. The mechanism and physiological function of macroautophagy. J Innate Immun. 2013;5(5):427–433.• Describes the general mechanisms of autophagy and its role in physiological processes.
25. G.M.Fimia, A.Stoykova, A.Romagnoli, et al. Ambra1 regulates autophagy and development of the nervous system. Nature. 2007;447(7148):1121–1125.
26. S.Pankiv, T.H.Clausen, T.Lamark, et al. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem. 2007;282(33):24131–24145.
27. E.Lee, Y.Koo, A.Ng, et al. Autophagy is essential for cardiac morphogenesis during vertebrate development. Autophagy. 2014;10(4):572–587.
28. A.Nakai, O.Yamaguchi, T.Takeda, et al. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat Med. 2007;13(5):619–624.
29. Y.Endo, A.Furuta, I.Nishino. Danon disease:a phenotypic expression of LAMP-2 deficiency. Acta Neuropathol. 2015;129(3):391–398.
30. G.Wang, W.Q.Huang, S.D.Cui, et al. Autophagy is involved in high glucose-induced heart tube malformation. Cell Cycle. 2015;14(5):772–783.
31. M.Taneike, O.Yamaguchi, A.Nakai, et al. Inhibition of autophagy in the heart induces age-related cardiomyopathy. Autophagy. 2010;6(5):600–606.
32. P.J.Linton, M.Gurney, D.Sengstock, et al. This old heart:cardiac aging and autophagy. J Mol Cell Cardiol. 2015;83:44–54.
33. S.Lavandero, M.Chiong, B.A.Rothermel, et al. Autophagy in cardiovascular biology. J Clin Invest. 2015;125(1):55–64.•• Explains the mechanisms involved in autophagy as well as its potential therapeutic targeting in the context of the cardiovascular system.
34. D.Gatica, M.Chiong, S.Lavandero, et al. Molecular mechanisms of autophagy in the cardiovascular system. Circ Res. 2015;116(3):456–467.
35. J.Ren, H.Taegtmeyer. Too much or not enough of a good thing–The Janus faces of autophagy in cardiac fuel and protein homeostasis. J Mol Cell Cardiol. 2015;84:223–226.
36. R.Troncoso, J.M.Vicencio, V.Parra, et al. Energy-preserving effects of IGF-1 antagonize starvation-induced cardiac autophagy. Cardiovasc Res. 2012;93(2):320–329.
37. Y.Yang, Y.Li, X.Chen, et al. Exosomal transfer of miR-30a between cardiomyocytes regulates autophagy after hypoxia. J Mol Med. 2016;94(6):711–724.
38. Y.Matsui, H.Takagi, X.Qu, et al. Distinct roles of autophagy in the heart during ischemia and reperfusion:roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ Res. 2007;100(6):914–922.
39. A.T.Turer, J.A.Hill. Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy. Am J Cardiol. 2010;106(3):360–368.
40. Y.Maejima, M.Isobe, J.Sadoshima. Regulation of autophagy by Beclin 1 in the heart. J Mol Cell Cardiol. 2015;95:19–25.
41. Z.Huang, Z.Han, B.Ye, et al. Berberine alleviates cardiac ischemia/reperfusion injury by inhibiting excessive autophagy in cardiomyocytes. Eur J Pharmacol. 2015;762:1–10.
42. N.Hariharan, P.Zhai, J.Sadoshima. Oxidative stress stimulates autophagic flux during ischemia/reperfusion. Antioxid Redox Signal. 2011;14(11):2179–2190.
43. X.Ma, H.Liu, S.R.Foyil, et al. Impaired autophagosome clearance contributes to cardiomyocyte death in ischemia/reperfusion injury. Circulation. 2012;125(25):3170–3181.
44. H.Zhu, P.Tannous, J.L.Johnstone, et al. Cardiac autophagy is a maladaptive response to hemodynamic stress. J Clin Invest. 2007;117(7):1782–1793.
45. M.Odashima, S.Usui, H.Takagi, et al. Inhibition of endogenous Mst1 prevents apoptosis and cardiac dysfunction without affecting cardiac hypertrophy after myocardial infarction. Circ Res. 2007;100(9):1344–1352.
46. Y.Maejima, S.Kyoi, P.Zhai, et al. Mst1 inhibits autophagy by promoting the interaction between Beclin1 and Bcl-2. Nat Med. 2013;19(11):1478–1488.
47. M.Xie, Y.Kong, W.Tan, et al. Histone deacetylase inhibition blunts ischemia/reperfusion injury by inducing cardiomyocyte autophagy. Circulation. 2014;129(10):1139–1151.
48. J.Zhang, S.M.Nadtochiy, W.R.Urciuoli, et al. The cardioprotective compound cloxyquin uncouples mitochondria and induces autophagy. Am J Physiol Heart Circ Physiol. 2016;310(1):H29–H38.
49. L.Huang, K.Dai, M.Chen, et al. The AMPK agonist PT1 and mTOR inhibitor 3HOI-BA-01 protect cardiomyocytes after ischemia through induction of autophagy. J Cardiovasc Pharmacol Ther. 2016;21(1):70–81.
50. K.Yang, C.Xu, X.Li, et al. Combination of D942 with curcumin protects cardiomyocytes from ischemic damage through promoting autophagy. J Cardiovasc Pharmacol Ther. 2013;18(6):570–581.
51. Z.Huang, B.Ye, Z.Dai, et al. Curcumin inhibits autophagy and apoptosis in hypoxia/reoxygenation-induced myocytes. Mol Med Rep. 2015;11(6):4678–4684.
52. Y.Hu, Q.Sun, Z.Li, et al. High basal level of autophagy in high-altitude residents attenuates myocardial ischemia-reperfusion injury. J Thorac Cardiovasc Surg. 2014;148(4):1674–1680.
53. J.Dammrich, U.Pfeifer. Cardiac hypertrophy in rats after supravalvular aortic constriction. II. Inhibition of cellular autophagy in hypertrophying cardiomyocytes. Virchows Arch B Cell Pathol Incl Mol Pathol. 1983;43(3):287–307.
54. H.Shimomura, F.Terasaki, T.Hayashi, et al. Autophagic degeneration as a possible mechanism of myocardial cell death in dilated cardiomyopathy. Jpn Circ J. 2001;65(11):965–968.
55. T.Saito, K.Asai, S.Sato, et al. Autophagic vacuoles in cardiomyocytes of dilated cardiomyopathy with initially decompensated heart failure predict improved prognosis. Autophagy. 2016;12(3):579–587.
56. P.Yu, Y.Zhang, C.Li, et al. Class III PI3K-mediated prolonged activation of autophagy plays a critical role in the transition of cardiac hypertrophy to heart failure. J Cell Mol Med. 2015;19(7):1710–1719.
57. X.Zhang, X.Min, C.Li, et al. Involvement of reductive stress in the cardiomyopathy in transgenic mice with cardiac-specific overexpression of heat shock protein 27. Hypertension. 2010;55(6):1412–1417.
58. G.G.Schiattarella, J.A.Hill. Therapeutic targeting of autophagy in cardiovascular disease. J Mol Cell Cardiol. 2015;95:86–93.•• Discusses the therapeutic potential of autophagy to treat cardiovascular diseases and the present limitations of this approach.
59. S.Khan, F.Salloum, A.Das, et al. Rapamycin confers preconditioning-like protection against ischemia-reperfusion injury in isolated mouse heart and cardiomyocytes. J Mol Cell Cardiol. 2006;41(2):256–264.
60. H.H.Chen, C.Mekkaoui, H.Cho, et al. Fluorescence tomography of rapamycin-induced autophagy and cardioprotection in vivo. Circ Cardiovasc Imaging. 2013;6(3):441–447.
61. C.P.Hsu, S.Oka, D.Shao, et al. Nicotinamide phosphoribosyltransferase regulates cell survival through NAD+ synthesis in cardiac myocytes. Circ Res. 2009;105(5):481–491.
62. C.P.Hsu, T.Yamamoto, S.Oka, et al. The function of nicotinamide phosphoribosyltransferase in the heart. DNA Repair. 2014;23:64–68.
63. C.P.Hsu, N.Hariharan, R.R.Alcendor, et al. Nicotinamide phosphoribosyltransferase regulates cell survival through autophagy in cardiomyocytes. Autophagy. 2009;5(8):1229–1231.
64. Y.Yang, W.Duan, Y.Li, et al. Novel role of silent information regulator 1 in myocardial ischemia. Circulation. 2013;128(20):2232–2240.
65. Q.Li, J.Xie, R.Li, et al. Overexpression of microRNA-99a attenuates heart remodelling and improves cardiac performance after myocardial infarction. J Cell Mol Med. 2014;18(5):919–928.
66. K.Higashi, Y.Yamada, S.Minatoguchi, et al. MicroRNA-145 repairs infarcted myocardium by accelerating cardiomyocyte autophagy. Am J Physiol Heart Circ Physiol. 2015;309(11):H1813–H1826.
67. K.Wang, C.Y.Liu, L.Y.Zhou, et al. APF lncRNA regulates autophagy and myocardial infarction by targeting miR-188-3p. Nat Commun. 2015;6:6779.
68. K.Bishu, O.Ogut, S.Kushwaha, et al. Anti-remodeling effects of rapamycin in experimental heart failure:dose response and interaction with angiotensin receptor blockade. PloS one. 2013;8(12):e81325.
69. Z.Xie, K.Lau, B.Eby, et al. Improvement of cardiac functions by chronic metformin treatment is associated with enhanced cardiac autophagy in diabetic OVE26 mice. Diabetes. 2011;60(6):1770–1778.
70. X.Xu, Z.Lu, J.Fassett, et al. Metformin protects against systolic overload-induced heart failure independent of AMP-activated protein kinase alpha2. Hypertension. 2014;63(4):723–728.
71. M.Yin, I.C.van der Horst, J.P.van Melle, et al. Metformin improves cardiac function in a nondiabetic rat model of post-MI heart failure. Am J Physiol Heart Circ Physiol. 2011;301(2):H459–H468.
72. R.Kishore, P.Krishnamurthy, V.N.Garikipati, et al. Interleukin-10 inhibits chronic angiotensin II-induced pathological autophagy. J Mol Cell Cardiol. 2015;89(Pt B):203–213.
73. A.Samanta, B.Dawn. IL-10 for cardiac autophagy modulation:new direction in the pursuit of perfection. J Mol Cell Cardiol. 2016;91:204–206.
74. S.Shoji-Kawata, R.Sumpter, M.Leveno, et al. Identification of a candidate therapeutic autophagy-inducing peptide. Nature. 2013;494(7436):201–206.
75. E.Wirawan, T.Vanden Berghe, S.Lippens, et al. Autophagy:for better or for worse. Cell Res. 2012;22(1):43–61.
76. S.Chera, W.Buzgariu, L.Ghila, et al. Autophagy in Hydra:a response to starvation and stress in early animal evolution. Biochim Biophys Acta. 2009;1793(9):1432–1443.
77. C.Gonzalez-Estevez, E.Salo. Autophagy and apoptosis in planarians. Apoptosis. 2010;15(3):279–292.
78. A.S.Azevedo, B.Grotek, A.Jacinto, et al. The regenerative capacity of the zebrafish caudal fin is not affected by repeated amputations. PloS one. 2011;6(7):e22820.
79. M.Varga, M.Sass, D.Papp, et al. Autophagy is required for zebrafish caudal fin regeneration. Cell Death Differ. 2014;21(4):547–556.
80. L.M.Buja, D.Vela. Cardiomyocyte death and renewal in the normal and diseased heart. Cardiovasc Pathol. 2008;17(6):349–374.
81. A.Leri, J.Kajstura, P.Anversa. Role of cardiac stem cells in cardiac pathophysiology:a paradigm shift in human myocardial biology. Circ Res. 2011;109(8):941–961.
82. M.Omatsu-Kanbe, H.Matsuura. Ischemic survival and constitutively active autophagy in self-beating atypically-shaped cardiomyocytes (ACMs):characterization of a new subpopulation of heart cells. J Physiol Sci. 2013;63(1):17–29.
83. K.Breckwoldt, F.Weinberger, T.Eschenhagen. Heart regeneration. Biochim Biophys Acta. 2015;1863(7 Pt B):1749–1759.
84. A.Uygur, R.T.Lee. Mechanisms of cardiac regeneration. Dev Cell. 2016;36(4):362–374.
85. A.Finan, S.Richard. Stimulating endogenous cardiac repair. Front Dev Biol. 2015;3:57.
86. M.I.Schaun, B.Eibel, M.Kristocheck, et al. Cell therapy in ischemic heart disease:interventions that modulate cardiac regeneration. Stem Cells Int. 2016;2016:2171035.
87. A.Terzic, A.Behfar. Stem cell therapy for heart failure:ensuring regenerative proficiency. Trends Cardiovasc Med. 2016;26(5):395–404.
88. R.Madonna, L.W.Van Laake, S.M.Davidson, et al. Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart:cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure. Eur Heart J. 2016;37(23):1789–1798.
89. H.Pan, N.Cai, M.Li, et al. Autophagic control of cell ‘stemness’. EMBO Mol Med. 2013;5(3):327–331.• Discusses the critical role of autophagy in stem cell regeneration.
90. J.Zhang, J.Liu, Y.Huang, et al. FRS2alpha-mediated FGF signals suppress premature differentiation of cardiac stem cells through regulating autophagy activity. Circ Res. 2012;110(4):e29–e39.
91. J.Zhang, J.Liu, L.Liu, et al. The fibroblast growth factor signaling axis controls cardiac stem cell differentiation through regulating autophagy. Autophagy. 2012;8(4):690–691.
92. T.Chen, L.Shen, J.Yu, et al. Rapamycin and other longevity-promoting compounds enhance the generation of mouse induced pluripotent stem cells. Aging Cell. 2011;10(5):908–911.
93. V.Karantalis, J.M.Hare. Use of mesenchymal stem cells for therapy of cardiac disease. Circ Res. 2015;116(8):1413–1430.
94. Y.Lee, J.Jung, K.J.Cho, et al. Increased SCF/c-kit by hypoxia promotes autophagy of human placental chorionic plate-derived mesenchymal stem cells via regulating the phosphorylation of mTOR. J Cell Biochem. 2013;114(1):79–88.
95. Z.Zhang, M.Yang, Y.Wang, et al. Autophagy regulates the apoptosis of bone marrow-derived mesenchymal stem cells under hypoxic condition via AMP-activated protein kinase/mammalian target of rapamycin pathway. Cell Biol Int. 2016;40(6):671–685.
96. C.Song, C.Song, F.Tong. Autophagy induction is a survival response against oxidative stress in bone marrow-derived mesenchymal stromal cells. Cytotherapy. 2014;16(10):1361–1370.
97. G.Mazzoccoli, M.F.Tevy, M.Borghesan, et al. Caloric restriction and aging stem cells:the stick and the carrot? Exp Gerontol. 2014;50:137–148.
98. L.Garcia-Prat, M.Martinez-Vicente, P.Munoz-Canoves. Autophagy:a decisive process for stemness. Oncotarget. 2016;7(11):12286–12288.
99. A.T.Vessoni, A.R.Muotri, O.K.Okamoto. Autophagy in stem cell maintenance and differentiation. Stem Cells Dev. 2012;21(4):513–520.
100. O.Ham, S.Y.Lee, C.Y.Lee, et al. let-7b suppresses apoptosis and autophagy of human mesenchymal stem cells transplanted into ischemia/reperfusion injured heart 7by targeting caspase-3. Stem Cell Res Ther. 2015;6:147.
101. S.Gallo, V.Sala, S.Gatti, et al. Cellular and molecular mechanisms of HGF/Met in the cardiovascular system. Clin Sci. 2015;129(12):1173–1193.
102. S.Gallo, S.Gatti, V.Sala, et al. Agonist antibodies activating the Met receptor protect cardiomyoblasts from cobalt chloride-induced apoptosis and autophagy. Cell Death Dis. 2014;5:e1185.
103. S.Neuss, E.Becher, M.Woltje, et al. Functional expression of HGF and HGF receptor/c-met in adult human mesenchymal stem cells suggests a role in cell mobilization, tissue repair, and wound healing. Stem Cells. 2004;22(3):405–414.
104. G.M.Ellison, D.Torella, S.Dellegrottaglie, et al. Endogenous cardiac stem cell activation by insulin-like growth factor-1/hepatocyte growth factor intracoronary injection fosters survival and regeneration of the infarcted pig heart. J Am Coll Cardiol. 2011;58(9):977–986.
105. S.Koudstaal, M.M.Bastings, D.A.Feyen, et al. Sustained delivery of insulin-like growth factor-1/hepatocyte growth factor stimulates endogenous cardiac repair in the chronic infarcted pig heart. J Cardiovasc Transl Res. 2014;7(2):232–241.
106. J.Chmielowiec, M.Borowiak, M.Morkel, et al. c-Met is essential for wound healing in the skin. J Cell Biol. 2007;177(1):151–162.
107. T.Ishikawa, V.M.Factor, J.U.Marquardt, et al. Hepatocyte growth factor/c-met signaling is required for stem-cell-mediated liver regeneration in mice. Hepatology. 2012;55(4):1215–1226.
108. M.T.Webster, C.M.Fan. c-MET regulates myoblast motility and myocyte fusion during adult skeletal muscle regeneration. PloS one. 2013;8(11):e81757.
109. R.Troncoso, C.Ibarra, J.M.Vicencio, et al. New insights into IGF-1 signaling in the heart. Trends Endocrinol Metab. 2014;25(3):128–137.
110. L.L.Bagno, D.Carvalho, F.Mesquita, et al. Sustained IGF-1 secretion by adipose-derived stem cell improves infarcted heart function. Cell Transplant. 2015. [Epub ahead of print].
111. R.Jackson, E.L.Tilokee, N.Latham, et al. Paracrine engineering of human cardiac stem cells with insulin-like growth factor 1 enhances myocardial repair. J Am Heart Assoc. 2015;4(9):e002104.
112. W.F.Cai, L.Wang, G.S.Liu, et al. Manipulating the Hippo-Yap signal cascade in stem cells for heart regeneration. Ann Palliat Med. 2016;5(2):125–134.
113. Y.Tian, Y.Liu, T.Wang, et al. A microRNA-Hippo pathway that promotes cardiomyocyte proliferation and cardiac regeneration in mice. Sci Transl Med. 2015;7(279):279ra238.
114. D.J.Cao, Z.V.Wang, P.K.Battiprolu, et al. Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy. Proc Natl Acad Sci U S A. 2011;108(10):4123–4128.
115. G.G.Schiattarella, J.A.Hill. Inhibition of hypertrophy is a good therapeutic strategy in ventricular pressure overload. Circulation. 2015;131(16):1435–1447.
116. C.Wang, S.Wang, P.Zhao, et al. MiR-221 promotes cardiac hypertrophy in vitro through the modulation of p27 expression. J Cell Biochem. 2012;113(6):2040–2046.
117. M.Su, J.Wang, C.Wang, et al. MicroRNA-221 inhibits autophagy and promotes heart failure by modulating the p27/CDK2/mTOR axis. Cell Death Differ. 2015;22(6):986–999.
118. A.Ucar, S.K.Gupta, J.Fiedler, et al. The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy. Nat Commun. 2012;3:1078.
119. Z.Li, Y.Song, L.Liu, et al. miR-199a impairs autophagy and induces cardiac hypertrophy through mTOR activation. Cell Death Differ. 2015. [Epub ahead of print].
120. W.Pan, Y.Zhong, C.Cheng, et al. MiR-30-regulated autophagy mediates angiotensin II-induced myocardial hypertrophy. PloS one. 2013;8(1):e53950.
121. J.Huang, W.Sun, H.Huang, et al. miR-34a modulates angiotensin II-induced myocardial hypertrophy by direct inhibition of ATG9A expression and autophagic activity. PloS one. 2014;9(4):e94382.
122. L.Song, M.Su, S.Wang, et al. MiR-451 is decreased in hypertrophic cardiomyopathy and regulates autophagy by targeting TSC1. J Cell Mol Med. 2014;18(11):2266–2274.
123. J.Viereck, R.Kumarswamy, A.Foinquinos, et al. Long noncoding RNA Chast promotes cardiac remodeling. Sci Transl Med. 2016;8(326):326ra322.
124. D.J.Luther, C.K.Thodeti, J.G.Meszaros. Injury models to study cardiac remodeling in the mouse:myocardial infarction and ischemia-reperfusion. Methods Mol Biol. 2013;1037:325–342.
125. P.Aranguiz-Urroz, J.Canales, M.Copaja, et al. Beta(2)-adrenergic receptor regulates cardiac fibroblast autophagy and collagen degradation. Biochim Biophys Acta. 2011;1812(1):23–31.
126. S.P.Georgescu, M.J.Aronovitz, J.L.Iovanna, et al. Decreased metalloprotease 9 induction, cardiac fibrosis, and higher autophagy after pressure overload in mice lacking the transcriptional regulator p8. Am J Physiol Cell Physiol. 2011;301(5):C1046–C1056.
127. J.M.Berry, V.Le, D.Rotter, et al. Reversibility of adverse, calcineurin-dependent cardiac remodeling. Circ Res. 2011;109(4):407–417.
128. H.He, X.Liu, L.Lv, et al. Calcineurin suppresses AMPK-dependent cytoprotective autophagy in cardiomyocytes under oxidative stress. Cell Death Dis. 2014;5:e997.
129. O.Vakhrusheva, C.Smolka, P.Gajawada, et al. Sirt7 increases stress resistance of cardiomyocytes and prevents apoptosis and inflammatory cardiomyopathy in mice. Circ Res. 2008;102(6):703–710.
130. S.Araki, Y.Izumiya, T.Rokutanda, et al. Sirt7 contributes to myocardial tissue repair by maintaining transforming growth factor-beta signaling pathway. Circulation. 2015;132(12):1081–1093.
131. S.Ghavami, R.H.Cunnington, S.Gupta, et al. Autophagy is a regulator of TGF-beta1-induced fibrogenesis in primary human atrial myofibroblasts. Cell Death Dis. 2015;6:e1696.
132. M.Zou, F.Wang, R.Gao, et al. Autophagy inhibition of hsa-miR-19a-3p/19b-3p by targeting TGF-beta R II during TGF-beta1-induced fibrogenesis in human cardiac fibroblasts. Sci Rep. 2016;6:24747.
133. A.Aguirre, N.Montserrat, S.Zacchigna, et al. In vivo activation of a conserved microRNA program induces mammalian heart regeneration. Cell Stem Cell. 2014;15(5):589–604.
134. T.Seeger, Q.F.Xu, M.Muhly-Reinholz, et al. Inhibition of let-7 augments the recruitment of epicardial cells and improves cardiac function after myocardial infarction. J Mol Cell Cardiol. 2016;94:145–152.
135. N.Shyh-Chang, G.Q.Daley, L.C.Cantley. Stem cell metabolism in tissue development and aging. Development. 2013;140(12):2535–2547.
136. E.T.Jun-Hao, R.R.Gupta, N.Shyh-Chang. Lin28 and let-7 in the metabolic physiology of aging. Trends Endocrinol Metab. 2016;27(3):132–141.
137. A.N.Dubinsky, S.G.Dastidar, C.L.Hsu, et al. Let-7 coordinately suppresses components of the amino acid sensing pathway to repress mTORC1 and induce autophagy. Cell Metab. 2014;20(4):626–638.
138. P.Jiang, N.Mizushima. Autophagy and human diseases. Cell Res. 2014;24(1):69–79.